
News|Articles|January 30, 2025
Rapid and Quantitative Screening of Nitrosamines in Drug Products Using Headspace-SIFT-MS
Author(s)Syft Technologies Inc
This study demonstrates that headspace-SIFT-MS meets United States Pharmacopeia (USP) criteria for six nitrosamines, achieving low limits of quantitation (0.06 ppm for NDMA and 0.03 ppm for NDEA) even in complex drug matrices. With high recovery rates and significant reductions in solvent usage, consumables, and operational complexity compared to traditional chromatographic methods, the Syft Tracer Pharm11 solution is an efficient screening tool for nitrosamines and volatile impurities.
Newsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Trending on LCGC International
1
Mass Spectrometry–Driven Strategies for Membrane Protein–Targeted Drug Discovery
2
Identification of Human Decomposition VOCs in Concrete Evidence Using HS-SPME GC–MS
3
Advanced Mass Spectrometry Techniques for Complex Therapeutics
4
Silicon-Micro-Nanofabrication in Analytical Chemistry—Possibilities Beyond Micro-Pillar Array Columns
5